BlackRock Institutional Trust’s Immunic IMUX Stock Holding History

BlackRock Institutional Trust’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.24M	Hold	1,286	–	–	﹤0.01%	3016
2016 Q3	$3.15M	Buy	1,286 +17	+1%	+$41.9K	﹤0.01%	2876
2016 Q2	$3.15M	Buy	1,269 +30	+2%	+$98.6K	﹤0.01%	2867
2016 Q1	$4.49M	Buy	1,239 +32	+3%	+$111K	﹤0.01%	2719
2015 Q4	$5.56M	Buy	1,207 +204	+20%	+$666K	﹤0.01%	2659
2015 Q3	$1.62M	Buy	1,003 +653	+187%	+$3.27M	﹤0.01%	3189
2015 Q2	$2.95M	Buy	350 +192	+122%	+$1.83M	﹤0.01%	2966
2015 Q1	$1.58M	Buy	158 +12	+8%	+$110K	﹤0.01%	3214
2014 Q4	$1.46M	Buy	146 +35	+32%	+$270K	﹤0.01%	3242
2014 Q3	$908K	Sell	111 -7	-6%	-$66.1K	﹤0.01%	3351
2014 Q2	$1.28M	Buy	+118	New	+$828K	﹤0.01%	3363

Other funds holding IMUX

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

BlackRock Institutional Trust's IMUX Position: Q4 2016 in Review

BlackRock Institutional Trust held its Immunic (IMUX) position steady in Q4 2016 at 1,286 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3016.

BlackRock Institutional Trust first reported a position in IMUX in Q2 2014 and has held it in 11 quarters since. The position peaked at $5.56M in Q4 2015. 55 funds tracked by Wall St. Rank hold IMUX as of Q4 2016.

BlackRock Institutional Trust held 1,286 shares of Immunic worth $2.24M as of Q4 2016.
BlackRock Institutional Trust left its Immunic share count unchanged in Q4 2016.
Immunic made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3016 holding.
BlackRock Institutional Trust first reported a position in Immunic in Q2 2014 and has held it in 11 quarters since.
BlackRock Institutional Trust's Immunic position peaked at $5.56M in Q4 2015.
55 funds tracked by Wall St. Rank held Immunic as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.